{"id":"W2920975913","doi":"10.1111/jdv.15480","title":"Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey‐based position statement","year":2019,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Innovaderm (Canada)","funders":"Chugai Pharmaceutical; LEO Pharma; LEO Fondet; Les Laboratories Pierre Fabre; Celgene; Valeant Pharmaceuticals International; Genzyme; AbbVie; Sanofi; Novartis; Amgen; LEO Pharma Research Foundation; Pfizer; Galderma; Eli Lilly and Company; MedImmune; GlaxoSmithKline","keywords":"Medicine; Atopic dermatitis; Position statement; Dermatology; Placebo; Position paper; Statement (logic); Clinical trial; Alternative medicine; Family medicine; Internal medicine; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.7338762,0.002654555,0.002775082,0.00441932,0.003369167,0.009200381,0.005127055,0.01425174,0.003561571],"category_scores_gemma":[0.6311395,0.001923266,0.004534644,0.005769142,0.00514396,0.006007825,0.008561941,0.01013145,0.002321878],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.008355522,"about_ca_system_score_gemma":0.06458247,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002214773,"about_ca_topic_score_gemma":0.004269082,"domain_scores_codex":[0.2624079,0.5801239,0.1065048,0.005625391,0.03945981,0.005878234],"domain_scores_gemma":[0.1698662,0.5192593,0.1095437,0.03784158,0.1465658,0.0169234],"domain_codex":"methods","domain_gemma":"methods","domain_candidate":"methods","domain_consensus":"methods","study_design_codex":"design_other","study_design_gemma":"qualitative","study_design_scores_codex":[0.0121797,0.001874506,0.04132309,0.02640136,0.002872679,0.0004382247,0.009319494,0.00613348,0.00702464,0.0252199,0.1883887,0.6788242],"study_design_scores_gemma":[0.01190169,0.01413096,0.09573475,0.04806508,0.0033456,0.0008550995,0.004608501,0.01344559,0.01002976,0.02835364,0.7686904,0.0008388388],"study_design_candidate":"qualitative","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.0402539,0.02767608,0.2184829,0.4948366,0.01302918,0.1542878,0.003994484,0.001561544,0.04587754],"genre_scores_gemma":[0.1646159,0.01024498,0.5114904,0.1464539,0.004315122,0.1555221,0.002615795,0.0003578753,0.004383938],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.2661238,"threshold_uncertainty_score":0.3281781,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1299320467437381,"score_gpt":0.3819166478588193,"score_spread":0.2519846011150813,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}